MMED Butterfly Strategy
MMED (MiniMed Group, Inc. Common Stock), in the Healthcare sector, (Medical - Equipment & Services industry), listed on NASDAQ.
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
MMED (MiniMed Group, Inc. Common Stock) trades in the Healthcare sector, specifically Medical - Equipment & Services, with a market capitalization of approximately $5.66B, a beta of -3.68 versus the broader market, a 52-week range of 10.65-20.88, average daily share volume of 995K, a public-listing history dating back to 2026, approximately 8K full-time employees. These structural characteristics shape how MMED stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -3.68 indicates MMED has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a butterfly on MMED?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
MMED snapshot
As of August 14, 2026, spot at $20.15, ATM IV 64.90%, expected move 18.61%. The butterfly on MMED below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this butterfly structure on MMED specifically: IV rank is unavailable in the current snapshot, so regime-based timing for MMED is inferred from ATM IV at 64.90% alone, with a market-implied 1-standard-deviation move of approximately 18.61% (roughly $3.75 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MMED expiries trade a higher absolute premium for lower per-day decay. Position sizing on MMED should anchor to the underlying notional of $20.15 per share and to the trader's directional view on MMED stock.
MMED butterfly setup
The MMED butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MMED at $20.15 on that close, the first option leg uses a $19.14 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MMED chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MMED shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $19.14 | N/A |
| Sell 2 | Call | $20.15 | N/A |
| Buy 1 | Call | $21.16 | N/A |
MMED butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
MMED butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on MMED. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on MMED
Butterflies on MMED are pinning bets - traders use them when they expect MMED to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
MMED thesis for this butterfly
The market-implied 1-standard-deviation range for MMED extends from approximately $16.40 on the downside to $23.90 on the upside. A MMED long call butterfly is a pinning play: it pays maximum at the middle strike if MMED settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. As a Healthcare name, MMED options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MMED-specific events.
MMED butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MMED positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MMED alongside the broader basket even when MMED-specific fundamentals are unchanged. Always rebuild the position from current MMED chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on MMED?
- A butterfly on MMED is the butterfly strategy applied to MMED (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With MMED stock at $20.15 on the most recent close, the strikes shown on this page are snapped to the nearest listed MMED chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are MMED butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the MMED butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 64.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MMED butterfly?
- The breakeven for the MMED butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The MMED market-implied 1-standard-deviation expected move in the same options snapshot is approximately 18.61%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on MMED?
- Butterflies on MMED are pinning bets - traders use them when they expect MMED to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current MMED implied volatility affect this butterfly?
- Current MMED ATM IV is 64.90%; IV rank context is unavailable in the current snapshot.